{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:00:00Z","timestamp":1787497200374,"version":"build-2736575974"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06051-4","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:07:41Z","timestamp":1751360861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Regulatory T cells and matrix-producing cancer associated fibroblasts contribute on the immune resistance and progression of prognosis related tumor subtypes in ccRCC"],"prefix":"10.1038","volume":"15","author":[{"given":"Chao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouji","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"6051_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"6051_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/14656566.2017.1282462","volume":"18","author":"C Porta","year":"2017","unstructured":"Porta, C. et al. Pharmacotherapy for treating metastatic clear cell renal cell carcinoma. Expert Opin. Pharmacother. 18, 205\u2013216. https:\/\/doi.org\/10.1080\/14656566.2017.1282462 (2017).","journal-title":"Expert Opin. Pharmacother."},{"key":"6051_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41571-019-0209-1","volume":"16","author":"RR Kotecha","year":"2019","unstructured":"Kotecha, R. R. et al. Towards individualized therapy for metastatic renal cell carcinoma. Nat. Rev. Clin. Oncol. 16, 621\u2013633. https:\/\/doi.org\/10.1038\/s41571-019-0209-1 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"6051_CR4","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","volume":"618","author":"A Gavish","year":"2023","unstructured":"Gavish, A. et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature 618, 598\u2013606. https:\/\/doi.org\/10.1038\/s41586-023-06130-4 (2023).","journal-title":"Nature"},{"key":"6051_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.trecan.2019.11.010","volume":"6","author":"L Gonzalez-Silva","year":"2020","unstructured":"Gonzalez-Silva, L. et al. Tumor Functional Heterogeneity Unraveled by scRNA-seq Technologies. Trends Cancer 6, 13\u201319. https:\/\/doi.org\/10.1016\/j.trecan.2019.11.010 (2020).","journal-title":"Trends Cancer"},{"key":"6051_CR6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41423-019-0214-4","volume":"16","author":"H Chen","year":"2019","unstructured":"Chen, H. et al. Revolutionizing immunology with single-cell RNA sequencing. Cell Mol. Immunol. 16, 242\u2013249. https:\/\/doi.org\/10.1038\/s41423-019-0214-4 (2019).","journal-title":"Cell Mol. Immunol."},{"key":"6051_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canlet.2021.12.008","volume":"527","author":"A Hernandez Martinez","year":"2022","unstructured":"Hernandez Martinez, A. et al. Unravelling glioblastoma heterogeneity by means of single-cell RNA sequencing. Cancer Lett. 527, 66\u201379. https:\/\/doi.org\/10.1016\/j.canlet.2021.12.008 (2022).","journal-title":"Cancer Lett."},{"key":"6051_CR8","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41587-021-01091-3","volume":"40","author":"D Sun","year":"2022","unstructured":"Sun, D. et al. Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data. Nat. Biotechnol. 40, 527\u2013538. https:\/\/doi.org\/10.1038\/s41587-021-01091-3 (2022).","journal-title":"Nat. Biotechnol."},{"key":"6051_CR9","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMra2302038","volume":"388","author":"CJ Haug","year":"2023","unstructured":"Haug, C. J. et al. Artificial Intelligence and Machine Learning in Clinical Medicine, 2023. N. Engl. J. Med. 388, 1201\u20131208. https:\/\/doi.org\/10.1056\/NEJMra2302038 (2023).","journal-title":"N. Engl. J. Med."},{"key":"6051_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.922929","author":"J Li","year":"2022","unstructured":"Li, J. et al. A risk signature based on necroptotic-process-related genes predicts prognosis and immune therapy response in kidney cell carcinoma. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.922929 (2022).","journal-title":"Front. Immunol."},{"key":"6051_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.874056","author":"F Liu","year":"2022","unstructured":"Liu, F. et al. Identification of Ligand-Receptor Pairs Associated With Tumour Characteristics in Clear Cell Renal Cell Carcinoma. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.874056 (2022).","journal-title":"Front Immunol."},{"key":"6051_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.818984","author":"Z Sun","year":"2022","unstructured":"Sun, Z. et al. Construction of a Lactate-Related Prognostic Signature for Predicting Prognosis, Tumor Microenvironment, and Immune Response in Kidney Renal Clear Cell Carcinoma. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.818984 (2022).","journal-title":"Front Immunol."},{"key":"6051_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s13167-023-00327-3","volume":"14","author":"J Liu","year":"2023","unstructured":"Liu, J. et al. Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework. EPMA J. 14, 275\u2013305. https:\/\/doi.org\/10.1007\/s13167-023-00327-3 (2023).","journal-title":"EPMA J."},{"key":"6051_CR14","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41467-022-28421-6","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat. Commun. 13, 816. https:\/\/doi.org\/10.1038\/s41467-022-28421-6 (2022).","journal-title":"Nat. Commun."},{"key":"6051_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41588-024-01662-5","volume":"56","author":"J Hu","year":"2024","unstructured":"Hu, J. et al. Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression. Nat. Genet. 56, 442\u2013457. https:\/\/doi.org\/10.1038\/s41588-024-01662-5 (2024).","journal-title":"Nat. Genet."},{"key":"6051_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A. et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420. https:\/\/doi.org\/10.1038\/nbt.4096 (2018).","journal-title":"Nat. Biotechnol."},{"key":"6051_CR17","doi-asserted-by":"publisher","unstructured":"McGinnis, C. S. et al. DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors. Cell Syst 8, 329\u2013337 e324, https:\/\/doi.org\/10.1016\/j.cels.2019.03.003 (2019).","DOI":"10.1016\/j.cels.2019.03.003"},{"key":"6051_CR18","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296. https:\/\/doi.org\/10.1038\/s41592-019-0619-0 (2019).","journal-title":"Nat. Methods"},{"key":"6051_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215834","author":"K Chen","year":"2022","unstructured":"Chen, K. et al. Single cell RNA-seq reveals the CCL5\/SDC1 receptor-ligand interaction between T cells and tumor cells in pancreatic cancer. Cancer Lett. https:\/\/doi.org\/10.1016\/j.canlet.2022.215834 (2022).","journal-title":"Cancer Lett."},{"key":"6051_CR20","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41587-021-01139-4","volume":"40","author":"V Kleshchevnikov","year":"2022","unstructured":"Kleshchevnikov, V. et al. Cell 2location maps fine-grained cell types in spatial transcriptomics. Nat. Biotechnol. 40, 661\u2013671. https:\/\/doi.org\/10.1038\/s41587-021-01139-4 (2022).","journal-title":"Nat. Biotechnol."},{"key":"6051_CR21","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s41596-020-0336-2","volume":"15","author":"B Van de Sande","year":"2020","unstructured":"Van de Sande, B. et al. A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat. Protoc. 15, 2247\u20132276. https:\/\/doi.org\/10.1038\/s41596-020-0336-2 (2020).","journal-title":"Nat. Protoc."},{"key":"6051_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2023.100498","author":"S Morabito","year":"2023","unstructured":"Morabito, S. et al. hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data. Cell Rep. Methods https:\/\/doi.org\/10.1016\/j.crmeth.2023.100498 (2023).","journal-title":"Cell Rep. Methods"},{"key":"6051_CR23","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using Cell Chat. Nat. Commun. 12, 1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9 (2021).","journal-title":"Nat. Commun."},{"key":"6051_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457. https:\/\/doi.org\/10.1038\/nmeth.3337 (2015).","journal-title":"Nat. Methods"},{"key":"6051_CR25","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782. https:\/\/doi.org\/10.1038\/s41587-019-0114-2 (2019).","journal-title":"Nat. Biotechnol."},{"key":"6051_CR26","doi-asserted-by":"publisher","unstructured":"Bonazzi, S. et al. Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy. Cell Chem Biol 30, 235\u2013247 e212, https:\/\/doi.org\/10.1016\/j.chembiol.2023.02.005 (2023).","DOI":"10.1016\/j.chembiol.2023.02.005"},{"key":"6051_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. Turning foes to friends: targeting cancer-associated fibroblasts. Nat. Rev. Drug Discov. 18, 99\u2013115. https:\/\/doi.org\/10.1038\/s41573-018-0004-1 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"6051_CR28","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/onc.2015.139","volume":"35","author":"F Guo","year":"2016","unstructured":"Guo, F. et al. CXCL12\/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks. Oncogene 35, 816\u2013826. https:\/\/doi.org\/10.1038\/onc.2015.139 (2016).","journal-title":"Oncogene"},{"key":"6051_CR29","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","volume":"26","author":"IG House","year":"2020","unstructured":"House, I. G. et al. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade. Clin. Cancer Res. 26, 487\u2013504. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-1868 (2020).","journal-title":"Clin. Cancer Res."},{"key":"6051_CR30","doi-asserted-by":"publisher","unstructured":"Jia, Y. et al. Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Esophageal Squamous Cell Carcinoma. Adv Sci (Weinh) 10, e2204565, https:\/\/doi.org\/10.1002\/advs.202204565 (2023).","DOI":"10.1002\/advs.202204565"},{"key":"6051_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102991","author":"L Gimeno","year":"2020","unstructured":"Gimeno, L. et al. KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers12102991 (2020).","journal-title":"Cancers (Basel)"},{"key":"6051_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112017","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. Machine learning-based integration develops a stress response stated T cell (Tstr)-related score for predicting outcomes in clear cell renal cell carcinoma. Int. Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2024.112017 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"6051_CR33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12885-025-13534-0","volume":"25","author":"F Lyu","year":"2025","unstructured":"Lyu, F. et al. Identification and validation of prognostic biomarkers in ccRCC: immune-stromal score and survival prediction. BMC Cancer 25, 148. https:\/\/doi.org\/10.1186\/s12885-025-13534-0 (2025).","journal-title":"BMC Cancer"},{"key":"6051_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102180","author":"J Luo","year":"2025","unstructured":"Luo, J. et al. Machine learning-derived natural killer cell signature predicts prognosis and therapeutic response in clear cell renal cell carcinoma. Transl. Oncol. https:\/\/doi.org\/10.1016\/j.tranon.2024.102180 (2025).","journal-title":"Transl. Oncol."},{"key":"6051_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107779","author":"R Liu","year":"2024","unstructured":"Liu, R. et al. Identification of prognostic coagulation-related signatures in clear cell renal cell carcinoma through integrated multi-omics analysis and machine learning. Comput. Biol. Med. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.107779 (2024).","journal-title":"Comput. Biol. Med."},{"key":"6051_CR36","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.eururo.2019.05.041","volume":"76","author":"MO Grimm","year":"2019","unstructured":"Grimm, M. O. et al. Safe Use of Immune Checkpoint Inhibitors in the Multidisciplinary Management of Urological Cancer: The European Association of Urology Position in 2019. Eur. Urol. 76, 368\u2013380. https:\/\/doi.org\/10.1016\/j.eururo.2019.05.041 (2019).","journal-title":"Eur. Urol."},{"key":"6051_CR37","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0140-6736(08)61039-9","volume":"372","author":"RJ Motzer","year":"2008","unstructured":"Motzer, R. J. et al. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet 372, 449\u2013456. https:\/\/doi.org\/10.1016\/S0140-6736(08)61039-9 (2008).","journal-title":"Lancet"},{"key":"6051_CR38","doi-asserted-by":"publisher","unstructured":"Krishna, C. et al. Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy. Cancer Cell 39, 662\u2013677 e666, https:\/\/doi.org\/10.1016\/j.ccell.2021.03.007 (2021).","DOI":"10.1016\/j.ccell.2021.03.007"},{"key":"6051_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41421-022-00415-0","volume":"8","author":"Z Long","year":"2022","unstructured":"Long, Z. et al. Single-cell multiomics analysis reveals regulatory programs in clear cell renal cell carcinoma. Cell Discov. 8, 68. https:\/\/doi.org\/10.1038\/s41421-022-00415-0 (2022).","journal-title":"Cell Discov."},{"key":"6051_CR40","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan, N. et al. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell 168, 613\u2013628. https:\/\/doi.org\/10.1016\/j.cell.2017.01.018 (2017).","journal-title":"Cell"},{"key":"6051_CR41","doi-asserted-by":"publisher","unstructured":"Turajlic, S. et al. Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal. Cell 173, 581\u2013594 e512, https:\/\/doi.org\/10.1016\/j.cell.2018.03.057 (2018).","DOI":"10.1016\/j.cell.2018.03.057"},{"key":"6051_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/cr.2016.151","volume":"27","author":"A Tanaka","year":"2017","unstructured":"Tanaka, A. et al. Regulatory T cells in cancer immunotherapy. Cell Res. 27, 109\u2013118. https:\/\/doi.org\/10.1038\/cr.2016.151 (2017).","journal-title":"Cell Res."},{"key":"6051_CR43","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1038\/s41416-024-02702-x","volume":"130","author":"S Santagata","year":"2024","unstructured":"Santagata, S. et al. Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients. Br. J. Cancer 130, 2016\u20132026. https:\/\/doi.org\/10.1038\/s41416-024-02702-x (2024).","journal-title":"Br. J. Cancer"},{"key":"6051_CR44","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s13046-019-1420-8","volume":"38","author":"C D'Alterio","year":"2019","unstructured":"D\u2019Alterio, C. et al. Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1. J. Exp. Clin. Cancer Res. 38, 432. https:\/\/doi.org\/10.1186\/s13046-019-1420-8 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"6051_CR45","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1038\/s41467-021-26091-4","volume":"12","author":"MC Kim","year":"2021","unstructured":"Kim, M. C. et al. CD177 modulates the function and homeostasis of tumor-infiltrating regulatory T cells. Nat. Commun. 12, 5764. https:\/\/doi.org\/10.1038\/s41467-021-26091-4 (2021).","journal-title":"Nat. Commun."},{"key":"6051_CR46","doi-asserted-by":"publisher","unstructured":"Overacre-Delgoffe, A. E. et al. Interferon-gamma Drives T(reg) Fragility to Promote Anti-tumor Immunity. Cell 169, 1130\u20131141 e1111, https:\/\/doi.org\/10.1016\/j.cell.2017.05.005 (2017).","DOI":"10.1016\/j.cell.2017.05.005"},{"key":"6051_CR47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00048.2019","volume":"101","author":"G Biffi","year":"2021","unstructured":"Biffi, G. et al. Diversity and Biology of Cancer-Associated Fibroblasts. Physiol. Rev. 101, 147\u2013176. https:\/\/doi.org\/10.1152\/physrev.00048.2019 (2021).","journal-title":"Physiol. Rev."},{"key":"6051_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1516","author":"B Chen","year":"2023","unstructured":"Chen, B. et al. The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional atlas. Clin. Transl. Med. https:\/\/doi.org\/10.1002\/ctm2.1516 (2023).","journal-title":"Clin. Transl. Med."},{"key":"6051_CR49","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1161\/CIRCRESAHA.121.320324","volume":"133","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. p53 Regulates the Extent of Fibroblast Proliferation and Fibrosis in Left Ventricle Pressure Overload. Circ. Res. 133, 271\u2013287. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.320324 (2023).","journal-title":"Circ. Res."},{"key":"6051_CR50","doi-asserted-by":"publisher","unstructured":"Huang, H. et al. Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer. Cancer Cell 40, 656\u2013673 e657, https:\/\/doi.org\/10.1016\/j.ccell.2022.04.011 (2022).","DOI":"10.1016\/j.ccell.2022.04.011"},{"key":"6051_CR51","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41573-022-00571-8","volume":"22","author":"O Hassin","year":"2023","unstructured":"Hassin, O. et al. Drugging p53 in cancer: one protein, many targets. Nat. Rev. Drug. Discov. 22, 127\u2013144. https:\/\/doi.org\/10.1038\/s41573-022-00571-8 (2023).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"6051_CR52","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.7150\/ijbs.82317","volume":"19","author":"Y Yang","year":"2023","unstructured":"Yang, Y. et al. CXCL12-CXCR4\/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications. Int. J. Biol. Sci. 19, 3341\u20133359. https:\/\/doi.org\/10.7150\/ijbs.82317 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"6051_CR53","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ng.2699","volume":"45","author":"Y Sato","year":"2013","unstructured":"Sato, Y. et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat. Genet. 45, 860\u2013867. https:\/\/doi.org\/10.1038\/ng.2699 (2013).","journal-title":"Nat. Genet."},{"key":"6051_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2023.102897","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. Machine Learning-Based Integration Develops a Macrophage-Related Index for Predicting Prognosis and Immunotherapy Response in Lung Adenocarcinoma. Arch. Med. Res. https:\/\/doi.org\/10.1016\/j.arcmed.2023.102897 (2023).","journal-title":"Arch. Med. Res."},{"key":"6051_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216594","author":"W Hong","year":"2024","unstructured":"Hong, W. et al. Deciphering the immune modulation through deep transcriptomic profiling and therapeutic implications of DNA damage repair pattern in hepatocellular carcinoma. Cancer Lett. https:\/\/doi.org\/10.1016\/j.canlet.2023.216594 (2024).","journal-title":"Cancer Lett."},{"key":"6051_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.108247","author":"W Liu","year":"2025","unstructured":"Liu, W. et al. A BRAF-activated noncoding RNA attenuates clear cell renal cell carcinoma via repression of glucose-6-phosphate dehydrogenase. J. Biol. Chem. https:\/\/doi.org\/10.1016\/j.jbc.2025.108247 (2025).","journal-title":"J. Biol. Chem."},{"key":"6051_CR57","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600200","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis, R. J. et al. Fundamentals of cancer metabolism. Sci. Adv. https:\/\/doi.org\/10.1126\/sciadv.1600200 (2016).","journal-title":"Sci. Adv."},{"key":"6051_CR58","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-024-02059-y","volume":"23","author":"Z Zhu","year":"2024","unstructured":"Zhu, Z. et al. PD1\/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives. Mol. Cancer 23, 146. https:\/\/doi.org\/10.1186\/s12943-024-02059-y (2024).","journal-title":"Mol. Cancer"},{"key":"6051_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.06.014","author":"S You","year":"2024","unstructured":"You, S. et al. Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunity. Cancer Cell https:\/\/doi.org\/10.1016\/j.ccell.2024.06.014 (2024).","journal-title":"Cancer Cell"},{"key":"6051_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-025-00942-1","author":"MB McKinnon","year":"2025","unstructured":"McKinnon, M. B. et al. Biomarker-informed care for patients with renal cell carcinoma. Nat. Cancer https:\/\/doi.org\/10.1038\/s43018-025-00942-1 (2025).","journal-title":"Nat. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06051-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06051-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06051-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:07:42Z","timestamp":1751360862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06051-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6051"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06051-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20533"}}